share_log

HOOKIPA Pharma | EFFECT: Others

HOOKIPA Pharma | EFFECT:其他

美股SEC公告 ·  01/05 13:00

牛牛AI助理已提取核心訊息

The United States Securities and Exchange Commission (SEC) has declared a Form S-3 filed by HOOKIPA Pharma Inc. effective as of January 4, 2024, at 4:01 P.M. This form is a registration statement that allows companies to issue various types of securities. The effectiveness of this form indicates that HOOKIPA Pharma has met all the necessary regulatory requirements to potentially offer securities to the public.
The United States Securities and Exchange Commission (SEC) has declared a Form S-3 filed by HOOKIPA Pharma Inc. effective as of January 4, 2024, at 4:01 P.M. This form is a registration statement that allows companies to issue various types of securities. The effectiveness of this form indicates that HOOKIPA Pharma has met all the necessary regulatory requirements to potentially offer securities to the public.
美國證券交易委員會(SEC)宣佈HOOKIPA Pharma Inc.提交的S-3表格自2024年1月4日下午 4:01 起生效。該表格是一份註冊聲明,允許公司發行各種類型的證券。該表格的有效性表明,HOOKIPA Pharma已滿足所有必要的監管要求,有可能向公衆提供證券。
美國證券交易委員會(SEC)宣佈HOOKIPA Pharma Inc.提交的S-3表格自2024年1月4日下午 4:01 起生效。該表格是一份註冊聲明,允許公司發行各種類型的證券。該表格的有效性表明,HOOKIPA Pharma已滿足所有必要的監管要求,有可能向公衆提供證券。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。